Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Annals of Hematology|November 27, 2012
Administration of recombinant erythropoietin alone does not improve the phenotype in iron refractory iron deficiency anemia patientsKai Lehmberg, Regine Grosse, Martina U Muckenthaler, et al.Haematologica|December 7, 2005
Effect of the histone deacetylase inhibitor depsipeptide on B-cell differentiation in both TEL-AML1-positive and negative childhood acute lymphoblastic leukemiaWendy A G Stams, Monique L den Boer, H Berna Beverloo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemiaWendy A G Stams, Monique L den Boer, H Berna Beverloo, et al.Haematologica|July 21, 2007
Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemiaAnja Troeger, Meinolf Siepermann, Gabriele Escherich, et al.Blood|February 19, 2005
Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemiaWendy A G Stams, Monique L den Boer, Amy Holleman, et al.Blood|June 17, 2008
High expression of CD40 on B-cell precursor acute lymphoblastic leukemia blasts is an independent risk factor associated with improved survival and enhanced capacity to up-regulate the death receptor CD95Anja Troeger, Ludmila Glouchkova, Birgit Ackermann, et al.Blood|November 16, 2002
Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALLWendy A G Stams, Monique L den Boer, H Berna Beverloo, et al.Cancer Cell|April 20, 2005
Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemiaSanne Lugthart, Meyling H Cheok, Monique L den Boer, et al.Blood|May 3, 2007
Outcome of treatment in children with hypodiploid acute lymphoblastic leukemiaJames B Nachman, Nyla A Heerema, Harland Sather, et al.Blood|October 31, 2002
Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemiaRonald W Stam, Monique L den Boer, Jules P P Meijerink, et al.Pageof 5